NDC 85160-300-03 - Turkfleks 5% Dextrose Water Solution
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85160-300
- Requested NDC
- 85160-300-03
- Package NDCs from labels
- 85160-300-01, 85160-300-10, 85160-300-02, 85160-300-20, 85160-300-03, 85160-300-30, 85160-300-04, 85160-300-40, 85160-300-05, 85160-300-50
- Manufacturer
- TURK ILAC VE SERUM SANAYI
- Effective date
- 2025-03-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Turkfleks 5% Dextrose Water Solution - TURK ILAC VE SERUM SANAYI | TURK ILAC VE SERUM SANAYI | 2025-03-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85160-300-01 | Turkfleks 5% Dextrose Water Solution | 100 mL in 1 BAG | INJECTION | 100 | 1 | |
| 85160-300-02 | Turkfleks 5% Dextrose Water Solution | 150 mL in 1 BAG | INJECTION | 150 | 1 | |
| 85160-300-03 | Turkfleks 5% Dextrose Water Solution | 250 mL in 1 BAG | INJECTION | 250 | 1 | |
| 85160-300-04 | Turkfleks 5% Dextrose Water Solution | 500 mL in 1 BAG | INJECTION | 500 | 1 | |
| 85160-300-05 | Turkfleks 5% Dextrose Water Solution | 1000 mL in 1 BAG | INJECTION | 1000 | 1 | |
| 85160-300-10 | Turkfleks 5% Dextrose Water Solution | 100 in 1 BOX | INJECTION | 100 | 1 | |
| 85160-300-20 | Turkfleks 5% Dextrose Water Solution | 100 in 1 BOX | INJECTION | 100 | 1 | |
| 85160-300-30 | Turkfleks 5% Dextrose Water Solution | 100 in 1 BOX | INJECTION | 100 | 1 | |
| 85160-300-40 | Turkfleks 5% Dextrose Water Solution | 100 in 1 BOX | INJECTION | 100 | 1 | |
| 85160-300-50 | Turkfleks 5% Dextrose Water Solution | 50 in 1 BOX | INJECTION | 50 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | 1795607 1795612 1795609 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | 1795609 1795610 |
| Dextrose | DEXTROSE | B. Braun Medical Inc. | 60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5 | 2026-05-12 | Warnings, Adverse reactions | 1795609 |
| Cell Energy Performance Drops 2048 | CELL ENERGY PERFORMANCE DROPS | Professional Complementary Health Formulas | 8701ea61-5d5f-466b-8d2c-f808e7b4d8fe | 2026-01-08 | Warnings | 5SL0G7R0OK |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | 1795609 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | 1795607 1795609 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | 1795621 1795607 1795612 1795609 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | 1795607 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | 1795609 |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | 1795607 1795612 1795609 1795610 |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 5SL0G7R0OK |
| 31ab2a1b-250e-5fc8-e063-6294a90a7359 | 31ab2a1b-250d-5fc8-e063-6294a90a7359 | 2025-03-31 | Warnings, Adverse reactions | 31ab2a1b-250e-5fc8-e063-6294a90a7359 31ab2a1b-250d-5fc8-e063-6294a90a7359 | ||
| Elliotts B | SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE | Lukare Medical, LLC | 08036dbd-55b3-47b9-9890-000f253544f3 | 2024-10-16 | Warnings, Adverse reactions | 5SL0G7R0OK |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | 1795607 1795612 1795609 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | 1795607 1795612 1795609 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | f2379398-a07b-417e-a022-f7b41f962067 | 2024-04-24 | Warnings, Adverse reactions | 1795607 1795612 1795609 1795610 |
| DEXTROSE | DEXTROSE | B. Braun Medical Inc. | 085614c7-ada4-4e2c-87c0-c9bc2f18365a | 2024-03-12 | Warnings, Adverse reactions | 1795607 1795612 1795610 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 9c80dfee-8923-4d1f-85b0-98bd68b94212 | 2022-12-07 | Warnings, Adverse reactions | 1795609 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 50603082-bce5-49eb-9737-e04239cfb695 | 2022-12-07 | Warnings, Adverse reactions | 1795609 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 0bfb32b2-d034-4219-a055-3448f0c424f7 | 2021-02-19 | Warnings, Adverse reactions | 1795609 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.